Category Archive

A pre-clinical vaccine candidate targeting the dangerous synthetic opioid fentanyl (FEN) was recently found to block its ability to enter the brain, thus eliminating the drug's "high."
The breakthrough discovery by researchers led by the University of Houston could have significant implications for the nation's opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids.
While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse. 

The most robust clinical evidence for the effectiveness of the monkeypox virus (MPX) vaccine was published today by the U.K. Health Security Agency (UKHSA).
The UKHSA estimates that the two-dose JYNNEOS® (MVA-BN, IMVAMUNE®) vaccine effectiveness for a single dose was 78% fourteen or more days after the initial vaccination.

Given the anticipated increase in respiratory infections this winter, America's healthcare professional organizations reminded the public of the importance of vaccinations and early treatment.
A strong recommendation from a trusted clinician is one of the most effective strategies to increase vaccine uptake, wrote these organizations on November 21, 2022. 

When asked, most parents say they have talked about vaccines with their child’s regular doctor in the past two years, most often discussing vaccines needed for school (82%).
And less often about flu shots (68%) or COVID-19 vaccination options (57%).
Fifteen percent of parents responded to a recent C.S. Mott Children’s Hospital National Poll published on November 21, 2022, saying they did not discuss vaccines with their child’s regular doctor.
Unfortunately, 6% of parents reported that their child does not get any vaccines.